Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning

BACKGROUND: Currently, there are no satisfactory biomarkers available to screen for diffuse large B cell lymphoma (DLBCL) or to identify patients who do not benefit from standard anti-cancer therapies. In this study, we used serum proteomic mass spectra to identify potential serum biomarkers and bio...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang, Xing, Wang, Bo, Zhang, Xiao-shi, Li, Zhi-ming, Guan, Zhong-zhen, Jiang, Wen-qi
Format: Artigo
Language:Inglês
Published: BioMed Central 2007
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2242801/
https://ncbi.nlm.nih.gov/pubmed/18163913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-7-235
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items